Metraipolis › archive › dc_5cb3d487a24a
Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective — Europe PMC PMID:41777881
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41777881
- DOI
- 10.3389/fimmu.2026.1711059
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T18:07:39.723Z
- SHA-256 of the archived text
b5ced32f0e28e4230f146b21b3918955902c0b260b648ceaa5113dd538727ece- Stable URL of this page
https://metraipolis.com/documento/dc_5cb3d487a24a
How to cite
Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective — Europe PMC PMID:41777881 — Europe PMC (en), https://europepmc.org/article/MED/41777881 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cb3d487a24a (Metraipolis archive dc_5cb3d487a24a, sha256 b5ced32f0e28e4230f146b21b3918955902c0b260b648ceaa5113dd538727ece)
BibTeX
@misc{dc5cb3d487a24a,
title = {Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective — Europe PMC PMID:41777881},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41777881},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cb3d487a24a; sha256 b5ced32f0e28e4230f146b21b3918955902c0b260b648ceaa5113dd538727ece},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41777881. Agents can read the archived copy with the MCP tool read_document.